Company information
- Ticker
- 1565
- Country
- Taiwan
- Sector
- Health Care
- Industry
- Biotech
St.Shine Business Summary
St.Shine Optical Co., Ltd. (1565.TWO) operates a high-volume manufacturing model centered on the production and global distribution of soft contact lenses, primarily through Original Design Manufacturing (ODM) and Original Equipment Manufacturing (OEM) partnerships. The company’s revenue is segmented into daily disposables, frequent replacement lenses, and specialty cosmetic/color lenses, with the majority of its top-line growth driven by exports to Japan, Europe, and other Asian markets. Domestically, it maintains a strong presence through its proprietary brand, TICON, which commands approximately 30% of the Taiwanese market. Within the competitive landscape, St.Shine ranks as a top-tier global ODM provider, competing directly with multinational giants such as Johnson & Johnson (Acuvue), Alcon, and CooperVision, as well as regional specialized players like Pegavision and Ginko International. The company is led by a veteran executive team with deep technical expertise in polymer materials and automated production. CEO Johnson Chou (Yue Jan Chou), who has held the position since 2001, oversees strategic operations and has been instrumental in scaling the firm’s manufacturing capacity; he holds a background in electronic engineering from Ta Hwa University of Science and Technology. Chairman Ming-Hsien Chen, a founding-era leader since 1986 representing Yun-Ming Investment Co., Ltd., brings extensive experience in the Greater China business landscape and holds an Honorary Ph.D. in Engineering. The leadership is supported by CFO Eris Lin and a board that includes long-tenured industry experts. Notable institutional backing includes the Vanguard Group, Dimensional Fund Advisors, and TransGlobe Life Insurance, reflecting the company’s established position as a stable, dividend-paying entity in the medical device sector.